AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8319654 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorinated water (20 ppm, 1.5 L per day)
Number of subjects: 60
Study 8319654 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 60
Study 3546223 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment transurethral resection (TUR)
Number of subjects: 494
Study 3546223 — intervention group
Group type: COMPARATOR
Intervention: Definitive irradiation to the prostate (6500‐7000 cGy) and regional lymphatics (4500‐5000 cGy)
Number of subjects: 494
Study 30633980 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine paracervical nerve block
Number of subjects: 95
Study 30633980 — intervention group
Group type: COMPARATOR
Intervention: Sham paracervical nerve block
Number of subjects: 95
Study 30633980 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall procedure duration
Number of subjects: 95
Study 27978579 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib 100 mg orally per day plus MK-2206 135 mg orally once per week
Number of subjects: 137
Study 27978579 — intervention group
Group type: COMPARATOR
Intervention: mFOLFOX (oxaliplatin 85 mg/m2 intravenous and fluorouracil 2400 mg/m2 intravenous infusion over 46-48 hours)
Number of subjects: 137
Study 25629634 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal naloxone (40 ng/24 h)
Number of subjects: 11
Study 25629634 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal naloxone (400 ng/24 h)
Number of subjects: 11
Study 25629634 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal morphine (control)
Number of subjects: 11
Study 23948221 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) treatment after 6 months
Number of subjects: 12
Study 23948221 — intervention group
Group type: COMPARATOR
Intervention: No treatment (before CPAP)
Number of subjects: 12
Study 21481064 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) applied on one side after FxCR treatment
Number of subjects: 25
Study 21481064 — intervention group
Group type: COMPARATOR
Intervention: Normal saline used as control on the contralateral side
Number of subjects: 25
Study 18446364 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-tasks condition with unpredictable task order
Number of subjects: 0
Study 18446364 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-tasks condition with predictable task order
Number of subjects: 0
Study 18446364 — intervention group
Group type: COMPARATOR
Intervention: Single-task condition
Number of subjects: 0
Study 16231341 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual therapy (IND)
Number of subjects: 86
Study 16231341 — intervention group
Group type: COMPARATOR
Intervention: Group therapy (GRP)
Number of subjects: 86
Study 15078380 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Analgesic Assessment Scale (CAAS)
Number of subjects: 69
Study 15078380 — intervention group
Group type: COMPARATOR
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 69
Study 10729392 — intervention group
Group type: EXPERIMENTAL
Intervention: Oleate (18:1 cis) meal
Number of subjects: 16
Study 10729392 — intervention group
Group type: EXPERIMENTAL
Intervention: Elaidate (18:1 trans) meal
Number of subjects: 16
Study 10729392 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmitate (16:0) meal
Number of subjects: 16
Study 10729392 — intervention group
Group type: EXPERIMENTAL
Intervention: Stearate (18:0) meal
Number of subjects: 16
Study 10729392 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT (8:0+10:0) meal
Number of subjects: 16
Study 10729392 — intervention group
Group type: COMPARATOR
Intervention: Low fat meal (10 g fat)
Number of subjects: 16
Study 8854774 — intervention group
Group type: COMPARATOR
Intervention: Arterial Embolization Chemotherapy (AEC)
Number of subjects: 32
Study 8854774 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Arterial Infusion Chemotherapy (CAIC)
Number of subjects: 32
Study 1451218 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine sulphate (4 mg in 10 ml saline)
Number of subjects: 10
Study 1451218 — intervention group
Group type: COMPARATOR
Intervention: Epidural saline (10 ml saline)
Number of subjects: 10
Study 6091475 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (1 g preoperatively)
Number of subjects: 129
Study 6091475 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 30684970 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose hCG at the time of GnRH-agonist trigger (Group 1)
Number of subjects: 71
Study 30684970 — intervention group
Group type: COMPARATOR
Intervention: Low-dose hCG at the time of oocyte retrieval (Group 2)
Number of subjects: 71
Study 29457493 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 50
Study 29457493 — intervention group
Group type: COMPARATOR
Intervention: No vitamin D supplementation
Number of subjects: 50
Study 29457493 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 50
Study 26742862 — intervention group
Group type: EXPERIMENTAL
Intervention: 27-gauge vitrectomy
Number of subjects: 66
Study 26742862 — intervention group
Group type: COMPARATOR
Intervention: 25-gauge vitrectomy
Number of subjects: 66
Study 24901088 — intervention group
Group type: EXPERIMENTAL
Intervention: High-soy diet (2 servings/day)
Number of subjects: 256
Study 24901088 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-soy diet (<3 servings/week)
Number of subjects: 256
Study 24901088 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline (no specific diet mentioned)
Number of subjects: 256
Study 24901088 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall association across diets
Number of subjects: 256
Study 24901088 — intervention group
Group type: EXPERIMENTAL
Intervention: Within diet periods
Number of subjects: 256
Study 22914593 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-learning aerobic exercise (6 minutes at 70% VO2 max on a stationary bicycle)
Number of subjects: 0
Study 19572092 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonates
Number of subjects: 0
Study 17926827 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone patches
Number of subjects: 1095
Study 17926827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1095
Study 15894699 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal and postnatal milk supplementation
Number of subjects: 951
Study 15894699 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 951
Study 12296782 — intervention group
Group type: EXPERIMENTAL
Intervention: Atridox
Number of subjects: 47
Study 12296782 — intervention group
Group type: COMPARATOR
Intervention: Elyzol Dental Gel
Number of subjects: 47
Study 12296782 — intervention group
Group type: COMPARATOR
Intervention: PerioChip
Number of subjects: 47
Study 10469093 — intervention group
Group type: EXPERIMENTAL
Intervention: FD Nd:YAG laser system 1
Number of subjects: 40
Study 10469093 — intervention group
Group type: EXPERIMENTAL
Intervention: FD Nd:YAG laser system 2
Number of subjects: 40
Study 10469093 — intervention group
Group type: EXPERIMENTAL
Intervention: FD Nd:YAG laser system 3
Number of subjects: 40
Study 10469093 — intervention group
Group type: EXPERIMENTAL
Intervention: FD Nd:YAG laser system 4
Number of subjects: 40
Study 10469093 — intervention group
Group type: COMPARATOR
Intervention: FD Nd:YAG lasers (all systems)
Number of subjects: 40
Study 7555368 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroetorphine hydrochloride (DHE)
Number of subjects: 90
Study 7555368 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 90
Study 7555368 — intervention group
Group type: COMPARATOR
Intervention: Control group (blank)
Number of subjects: 90
Study 1433772 — intervention group
Group type: EXPERIMENTAL
Intervention: Body positions and splints (alternative positions and splinting devices)
Number of subjects: 144
Study 1433772 — intervention group
Group type: COMPARATOR
Intervention: Standard supine position
Number of subjects: 144
Study 6697637 — intervention group
Group type: EXPERIMENTAL
Intervention: Carteolol 0.5 to 60 mg daily
Number of subjects: 0
Study 30995204 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents with higher educational level
Number of subjects: 789
Study 30995204 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents from higher socio-economic class
Number of subjects: 789
Study 30995204 — intervention group
Group type: COMPARATOR
Intervention: Overall population
Number of subjects: 789
Study 29596524 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tsDCS/treadmill exercise
Number of subjects: 12
Study 29596524 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tsDCS/treadmill exercise
Number of subjects: 12
Study 29596524 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency rTMS/treadmill exercise
Number of subjects: 12
Study 29596524 — intervention group
Group type: EXPERIMENTAL
Intervention: 20Hz rTMS/treadmill exercise
Number of subjects: 12
Study 29596524 — intervention group
Group type: COMPARATOR
Intervention: Sham conditions
Number of subjects: 12
Study 26351400 — intervention group
Group type: EXPERIMENTAL
Intervention: Double row of sutures
Number of subjects: 36
Study 26351400 — intervention group
Group type: COMPARATOR
Intervention: Control group (single row of sutures)
Number of subjects: 36
Study 23604641 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive stretching
Number of subjects: 0
Study 23604641 — intervention group
Group type: COMPARATOR
Intervention: Supervised neglect
Number of subjects: 0
Study 23604641 — intervention group
Group type: COMPARATOR
Intervention: Control (normal subjects)
Number of subjects: 0
Study 21757183 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinolysis
Number of subjects: 1572
Study 21757183 — intervention group
Group type: EXPERIMENTAL
Intervention: pPCI
Number of subjects: 1572
Study 21757183 — intervention group
Group type: COMPARATOR
Intervention: pPCI with system delay of 1 to 2 hours
Number of subjects: 1572
Study 21757183 — intervention group
Group type: COMPARATOR
Intervention: pPCI with system delay >3 hours
Number of subjects: 1572
Study 19685848 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbopelvic (LP) manipulation technique
Number of subjects: 60
Study 19685848 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar neutral gap (NG) manipulation technique
Number of subjects: 60
Study 17117002 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid functional electrical stimulation therapy on extensor carpi radialis longus and brevis, extensor digitorum communis, and extensor indicis proprius muscles, once or twice a week for 4 months after motor point blocks at the spastic finger flexor muscles
Number of subjects: 16
Study 17117002 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 16
Study 15065610 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 88 microg twice daily
Number of subjects: 160
Study 15065610 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 440 microg twice daily
Number of subjects: 160
Study 15065610 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 11704394 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 1102
Study 11704394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1102
Study 9148533 — intervention group
Group type: EXPERIMENTAL
Intervention: Free fat transplantation
Number of subjects: 99
Study 9148533 — intervention group
Group type: COMPARATOR
Intervention: Control (no free fat transplantation)
Number of subjects: 99
Study 1586175 — intervention group
Group type: EXPERIMENTAL
Intervention: Exosurf (2 doses in 24 hours)
Number of subjects: 73
Study 1586175 — intervention group
Group type: EXPERIMENTAL
Intervention: Exosurf (4 doses in 36 hours)
Number of subjects: 73
Study 1586175 — intervention group
Group type: COMPARATOR
Intervention: Control (no Exosurf)
Number of subjects: 73
Study 3841775 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine 100 mg/die/p.o.
Number of subjects: 20
Study 3841775 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg/die/p.o.
Number of subjects: 20
Study 3841775 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (Pirenzepine and Ranitidine)
Number of subjects: 20
Study 31805923 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey with standard drink term and pictorial guide
Number of subjects: 407
Study 31805923 — intervention group
Group type: COMPARATOR
Intervention: Survey without standard drink term and pictorial guide
Number of subjects: 407
Study 31805923 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent drinkers among US students
Number of subjects: 407
Study 29549681 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultracision
Number of subjects: 250
Study 29549681 — intervention group
Group type: COMPARATOR
Intervention: Ligasure
Number of subjects: 250
Study 27335049 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisaborole topical ointment, 2%, applied twice daily for 21 days
Number of subjects: 32
Study 27335049 — intervention group
Group type: COMPARATOR
Intervention: Vehicle ointment, applied twice daily for 21 days
Number of subjects: 32
Study 24094494 — intervention group
Group type: EXPERIMENTAL
Intervention: 12‐wk whole body vibration (WBV) intervention
Number of subjects: 50
Study 23170964 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated community-based, intensive chronic condition management facilitated by Indigenous Health Workers (IHWs)
Number of subjects: 0
Study 23170964 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 20860555 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 20
Study 20860555 — intervention group
Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 20
Study 18515810 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold Assessment Grid (TAG) rating of mental health problem severity
Number of subjects: 408839
Study 18515810 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-referral primary care contact rates for intervention group GPs
Number of subjects: 408839
Study 16114089 — intervention group
Group type: EXPERIMENTAL
Intervention: Butterbur extract (Ze 339; 8 mg total petasine; one tablet thrice‐daily)
Number of subjects: 330
Study 16114089 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine (Telfast 180; one tablet once‐daily)
Number of subjects: 330
Study 16114089 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study 12187615 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO
Number of subjects: 6
Study 12187615 — intervention group
Group type: COMPARATOR
Intervention: PLA
Number of subjects: 6
Study 10526824 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.3 ng/ml
Number of subjects: 45
Study 10526824 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.6 ng/ml
Number of subjects: 45
Study 10526824 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 7726352 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 124
Study 7726352 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 124
Study 7726352 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine and Bupivacaine
Number of subjects: 124
Study 7726352 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 124
Study 7726352 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall pattern in all patients
Number of subjects: 124
Study 2247104 — intervention group
Group type: EXPERIMENTAL
Intervention: Nystatin (oral and vaginal)
Number of subjects: 42
Study 2247104 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral and vaginal)
Number of subjects: 42
Study 2247104 — intervention group
Group type: EXPERIMENTAL
Intervention: All regimens (including placebo)
Number of subjects: 42
Study 6451637 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg/day of 13‐cis‐retinoic acid
Number of subjects: 14
Study 6451637 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg/day of 13‐cis‐retinoic acid
Number of subjects: 14
Study 6451637 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg/day of 13‐cis‐retinoic acid
Number of subjects: 14
Study 31682682 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Medical Visits with Intensive Weight Management (WM/GMV)
Number of subjects: 263
Study 31682682 — intervention group
Group type: COMPARATOR
Intervention: Group Medical Visits (GMV)
Number of subjects: 263
Study 31104138 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuchs’ uveitis syndrome (FUS)
Number of subjects: 21
Study 31104138 — intervention group
Group type: COMPARATOR
Intervention: Healthy eyes (N)
Number of subjects: 21
Study 28381530 — intervention group
Group type: COMPARATOR
Intervention: 0 g protein (control)
Number of subjects: 35
Study 28381530 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g protein
Number of subjects: 35
Study 28381530 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g protein
Number of subjects: 35
Study 28381530 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g protein
Number of subjects: 35
Study 25467562 — intervention group
Group type: EXPERIMENTAL
Intervention: SAFETY intervention
Number of subjects: 335
Study 25467562 — intervention group
Group type: COMPARATOR
Intervention: Standard management
Number of subjects: 335
Study 23823371 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated vital sign collection
Number of subjects: 60
Study 23823371 — intervention group
Group type: COMPARATOR
Intervention: Manual vital sign collection
Number of subjects: 60
Study 21429220 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered device
Number of subjects: 102
Study 21429220 — intervention group
Group type: COMPARATOR
Intervention: Manual device
Number of subjects: 102
Study 19434489 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid-job-placement supported employment
Number of subjects: 0
Study 19434489 — intervention group
Group type: COMPARATOR
Intervention: Services-as-usual comparison conditions
Number of subjects: 0
Study 18251439 — intervention group
Group type: EXPERIMENTAL
Intervention: Submerged upright position
Number of subjects: 6
Study 18251439 — intervention group
Group type: EXPERIMENTAL
Intervention: Submerged prone position
Number of subjects: 6
Study 14719691 — intervention group
Group type: EXPERIMENTAL
Intervention: Template-based correction of brain MRI intensity distortion
Number of subjects: 0
Study 11485708 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (88 mg twice daily)
Number of subjects: 338
Study 11485708 — intervention group
Group type: COMPARATOR
Intervention: Zafirlukast (20 mg twice daily)
Number of subjects: 338
Study 11485708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 338
Study 9674734 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH) - continuous i.v. infusion (450 U/kg/24 h, n = 6)
Number of subjects: 18
Study 9674734 — intervention group
Group type: COMPARATOR
Intervention: Low molecular weight heparin (LMWH) - enoxaparin, s.c. treatment (1.5 mg/kg, n = 12)
Number of subjects: 18
Study 7988629 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem CR 120 mg b.i.d. for 4 weeks
Number of subjects: 23
Study 7988629 — intervention group
Group type: COMPARATOR
Intervention: Plain diltiazem tablets 60 mg q.i.d. for 4 weeks
Number of subjects: 23
Study 2522147 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular route (IM group)
Number of subjects: 165
Study 2522147 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal route (ID group)
Number of subjects: 165
Study 2522147 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 165
Study 31100085 — intervention group
Group type: EXPERIMENTAL
Intervention: Best Possible Self condition
Number of subjects: 78
Study 31100085 — intervention group
Group type: EXPERIMENTAL
Intervention: One’s best self in the present
Number of subjects: 78
Study 31100085 — intervention group
Group type: EXPERIMENTAL
Intervention: One’s best self in the past
Number of subjects: 78
Study 28476479 — intervention group
Group type: EXPERIMENTAL
Intervention: LUCAS‐2 mechanical device for CPR
Number of subjects: 4471
Study 28476479 — intervention group
Group type: COMPARATOR
Intervention: Manual chest compressions (control)
Number of subjects: 4471
Study 25319535 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in the use of a BPSD-structured clinical protocol, plus external clinical support
Number of subjects: 204
Study 25319535 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop on BPSD, plus external clinical support
Number of subjects: 204
Study 25319535 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in the use of the structured clinical protocol alone
Number of subjects: 204
Study 25319535 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 204
Study 23352081 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) applied to extraction sockets immediately after extraction
Number of subjects: 25
Study 23352081 — intervention group
Group type: COMPARATOR
Intervention: Control (no PRP applied to extraction sockets)
Number of subjects: 25
Study 20651013 — intervention group
Group type: EXPERIMENTAL
Intervention: Core Stabilization Exercise Program (CSEP)
Number of subjects: 1141
Study 20651013 — intervention group
Group type: COMPARATOR
Intervention: Traditional Exercise Program (TEP)
Number of subjects: 1141
Study 20651013 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CSEP and TEP
Number of subjects: 1141
Study 18047764 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticonvulsant mood stabilizers (carbamazepine, valproic acid)
Number of subjects: 7
Study 16879470 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled hypotension (CH) induced with esmolol
Number of subjects: 56
Study 16879470 — intervention group
Group type: COMPARATOR
Intervention: Acute normovolemic hemodilution (ANH) only
Number of subjects: 56
Study 12748244 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg/d gefitinib
Number of subjects: 210
Study 12748244 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg/d gefitinib
Number of subjects: 210
Study 10817716 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemifloxacin 20 mg
Number of subjects: 0
Study 10817716 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemifloxacin 40 mg
Number of subjects: 0